
### [MONDO:0019305](http://purl.obolibrary.org/obo/MONDO_0019305)
**Label:** immune deficiency with skin involvement

**Subclasses:** [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0015279](http://purl.obolibrary.org/obo/MONDO_0015279) (chronic mucocutaneous candidiasis (disease)), [MONDO:0014642](http://purl.obolibrary.org/obo/MONDO_0014642) (candidiasis, familial, 9), [MONDO:0009176](http://purl.obolibrary.org/obo/MONDO_0009176) (epidermodysplasia verruciformis), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0008963](http://purl.obolibrary.org/obo/MONDO_0008963) (Chediak-Higashi syndrome), [MONDO:0012508](http://purl.obolibrary.org/obo/MONDO_0012508) (agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome), [MONDO:0008905](http://purl.obolibrary.org/obo/MONDO_0008905) (predisposition to invasive fungal disease due to CARD9 deficiency), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0010587](http://purl.obolibrary.org/obo/MONDO_0010587) (epidermodysplasia verruciformis, X-linked), [MONDO:0013779](http://purl.obolibrary.org/obo/MONDO_0013779) (Wiskott-Aldrich syndrome 2), [MONDO:0011872](http://purl.obolibrary.org/obo/MONDO_0011872) (Griscelli syndrome type 2), [MONDO:0013599](http://purl.obolibrary.org/obo/MONDO_0013599) (autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0017787](http://purl.obolibrary.org/obo/MONDO_0017787) (erythroderma desquamativum), [MONDO:0013140](http://purl.obolibrary.org/obo/MONDO_0013140) (candidiasis, familial, 4), [MONDO:0014230](http://purl.obolibrary.org/obo/MONDO_0014230) (candidiasis, familial, 8), [MONDO:0009540](http://purl.obolibrary.org/obo/MONDO_0009540) (Lymphokine deficiency), [MONDO:0011880](http://purl.obolibrary.org/obo/MONDO_0011880) (CANDF3), [MONDO:0014353](http://purl.obolibrary.org/obo/MONDO_0014353) (PGM3-CDG), [MONDO:0007818](http://purl.obolibrary.org/obo/MONDO_0007818) (Job's syndrome), [MONDO:0009645](http://purl.obolibrary.org/obo/MONDO_0009645) (Monocyte chemotactic disorder), [MONDO:0008017](http://purl.obolibrary.org/obo/MONDO_0008017) (hereditary mucoepithelial dysplasia), [MONDO:0009306](http://purl.obolibrary.org/obo/MONDO_0009306) (combined immunodeficiency with skin granulomas), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0010518](http://purl.obolibrary.org/obo/MONDO_0010518) (Wiskott-Aldrich syndrome), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0007257](http://purl.obolibrary.org/obo/MONDO_0007257) (CANDF1), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0013500](http://purl.obolibrary.org/obo/MONDO_0013500) (candidiasis, familial, 5), [MONDO:0010954](http://purl.obolibrary.org/obo/MONDO_0010954) (Wiskott-Aldrich syndrome, autosomal dominant form), [MONDO:0013503](http://purl.obolibrary.org/obo/MONDO_0013503) (candidiasis, familial, 6), 

**Corr. equiv. classes:** [Orphanet:157949](http://www.orpha.net/ORDO/Orphanet_157949), [OMIM:158310](http://purl.obolibrary.org/obo/OMIM_158310), [Orphanet:167](http://www.orpha.net/ORDO/Orphanet_167), [OMIM:306400](http://purl.obolibrary.org/obo/OMIM_306400), [OMIM:226400](http://purl.obolibrary.org/obo/OMIM_226400), [OMIM:147060](http://purl.obolibrary.org/obo/OMIM_147060), [OMIM:600903](http://purl.obolibrary.org/obo/OMIM_600903), [OMIM:614493](http://purl.obolibrary.org/obo/OMIM_614493), [Orphanet:1334](http://www.orpha.net/ORDO/Orphanet_1334), [Orphanet:457088](http://www.orpha.net/ORDO/Orphanet_457088), [OMIM:613960](http://purl.obolibrary.org/obo/OMIM_613960), [OMIM:214500](http://purl.obolibrary.org/obo/OMIM_214500), [OMIM:233700](http://purl.obolibrary.org/obo/OMIM_233700), [OMIM:305350](http://purl.obolibrary.org/obo/OMIM_305350), [OMIM:613108](http://purl.obolibrary.org/obo/OMIM_613108), [OMIM:615527](http://purl.obolibrary.org/obo/OMIM_615527), [Orphanet:379](http://www.orpha.net/ORDO/Orphanet_379), [Orphanet:79477](http://www.orpha.net/ORDO/Orphanet_79477), [Orphanet:314](http://www.orpha.net/ORDO/Orphanet_314), [OMIM:301000](http://purl.obolibrary.org/obo/OMIM_301000), [Orphanet:391487](http://www.orpha.net/ORDO/Orphanet_391487), [OMIM:607644](http://purl.obolibrary.org/obo/OMIM_607644), [Orphanet:83617](http://www.orpha.net/ORDO/Orphanet_83617), [OMIM:607624](http://purl.obolibrary.org/obo/OMIM_607624), [Orphanet:1839](http://www.orpha.net/ORDO/Orphanet_1839), [OMIM:138990](http://purl.obolibrary.org/obo/OMIM_138990), [OMIM:114580](http://purl.obolibrary.org/obo/OMIM_114580), [OMIM:614162](http://purl.obolibrary.org/obo/OMIM_614162), [OMIM:247650](http://purl.obolibrary.org/obo/OMIM_247650), [OMIM:252250](http://purl.obolibrary.org/obo/OMIM_252250), [OMIM:616445](http://purl.obolibrary.org/obo/OMIM_616445), [OMIM:610483](http://purl.obolibrary.org/obo/OMIM_610483), [Orphanet:443811](http://www.orpha.net/ORDO/Orphanet_443811), [Orphanet:906](http://www.orpha.net/ORDO/Orphanet_906), [OMIM:613953](http://purl.obolibrary.org/obo/OMIM_613953), [OMIM:233710](http://purl.obolibrary.org/obo/OMIM_233710), [OMIM:615816](http://purl.obolibrary.org/obo/OMIM_615816), [OMIM:233690](http://purl.obolibrary.org/obo/OMIM_233690), [OMIM:613956](http://purl.obolibrary.org/obo/OMIM_613956), [OMIM:277970](http://purl.obolibrary.org/obo/OMIM_277970), [Orphanet:302](http://www.orpha.net/ORDO/Orphanet_302), [OMIM:233650](http://purl.obolibrary.org/obo/OMIM_233650), [OMIM:212050](http://purl.obolibrary.org/obo/OMIM_212050), [Orphanet:2314](http://www.orpha.net/ORDO/Orphanet_2314), [OMIM:233670](http://purl.obolibrary.org/obo/OMIM_233670), 

**Class expressions from DL-Learner:**

- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 49.45%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 49.45%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and (not ([HP:0004313](http://purl.obolibrary.org/obo/HP_0004313) (Decreased antibody level in blood))) 49.16%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and (not ([HP:0010701](http://purl.obolibrary.org/obo/HP_0010701) (Abnormal immunoglobulin level))) 48.51%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and (not ([HP:0005372](http://purl.obolibrary.org/obo/HP_0005372) (Abnormality of B cell physiology))) 48.51%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and (not ([HP:0005368](http://purl.obolibrary.org/obo/HP_0005368) (Abnormality of humoral immunity))) 48.51%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and (not ([HP:0002846](http://purl.obolibrary.org/obo/HP_0002846) (Abnormality of B cells))) 48.51%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 47.64%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 47.64%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) 47.30%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 46.07%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) 45.90%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 45.66%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 45.50%
- [HP:0002841](http://purl.obolibrary.org/obo/HP_0002841) (Recurrent fungal infections) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 45.50%


